{
    "Trade/Device Name(s)": [
        "VITROS Chemistry Products HbA1c Reagent Kit",
        "VITROS Chemistry Products Calibrator Kit 31",
        "VITROS Chemistry Products %A1c Performance Verifiers I and II"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K142595",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121291",
        "K052101",
        "K041764"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PDJ",
        "JJY",
        "JIT"
    ],
    "Summary Letter Date": "April 27, 2015",
    "Summary Letter Received Date": "April 28, 2015",
    "Submission Date": "September 12, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1373",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay",
        "Calibrator",
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glycated Hemoglobin (HbA1c)",
        "Hemoglobin",
        "%A1c (derived)"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "VITROS 5,1 FS Chemistry System",
        "VITROS 4600 Chemistry System",
        "VITROS 5600 Integrated System"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric assay",
        "Bichromatic absorbance measurement"
    ],
    "Methodologies": [
        "Antibody-based inhibition",
        "Turbidimetric immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS Chemistry Products HbA1c Reagent Kit, Calibrator Kit 31, and %A1c Performance Verifiers for quantitative determination of percent glycated hemoglobin A1c in human whole blood",
    "Indications for Use Summary": "Used for the quantitative determination of percent glycated hemoglobin A1c in human whole blood as an aid in diabetes diagnosis, identifying patients at risk for diabetes mellitus, and monitoring long-term blood glucose control in individuals with diabetes mellitus",
    "fda_folder": "Clinical Chemistry"
}